Fundus autofluorescence imaging in age-related macular degeneration and geographic atrophy.

[1]  Jens Dreyhaupt,et al.  Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. , 2007, American journal of ophthalmology.

[2]  C. Keilhauer,et al.  Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration , 2005, British Journal of Ophthalmology.

[3]  P. Jong.  Prevalence of age-related macular degeneration in the United States. , 2004 .

[4]  C K Dorey,et al.  In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. , 1995, Investigative ophthalmology & visual science.

[5]  D. Bok,et al.  Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. , 2005, Investigative ophthalmology & visual science.

[6]  Noemi Lois,et al.  Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. , 2002, American journal of ophthalmology.

[7]  M. Tso,et al.  TEMPOL, a superoxide dismutase mimic, ameliorates light-induced retinal degeneration. , 1995, Research communications in molecular pathology and pharmacology.

[8]  E. Rimm,et al.  A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. , 2007, Archives of ophthalmology.

[9]  Eyal Margalit,et al.  The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. , 2007, Ophthalmology.

[10]  Weng Tao,et al.  Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J S Sunness,et al.  Measuring geographic atrophy in advanced age-related macular degeneration. , 1999, Investigative ophthalmology & visual science.

[12]  Sebastian Wolf,et al.  Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  C Bellman,et al.  Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. , 2001, Investigative ophthalmology & visual science.

[14]  C K Dorey,et al.  Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. , 2001, Investigative ophthalmology & visual science.

[15]  R. Klein,et al.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.

[16]  A. Bird,et al.  Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. , 2004, Investigative ophthalmology & visual science.

[17]  K. Nakanishi,et al.  A2E, a byproduct of the visual cycle , 2003, Vision Research.

[18]  J. Dreyhaupt,et al.  Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. , 2004, Investigative ophthalmology & visual science.